iTeos Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	207.82	142.13	251.18	284.8	848.54	336.33
Short-Term Investments	307.61	352.52	280.74	328.36	-	-
Cash & Short-Term Investments	515.43	494.65	531.92	613.16	848.54	336.33
Cash Growth	-9.77%	-7.01%	-13.25%	-27.74%	152.30%	1592.80%
Other Receivables	2.55	3.69	6.5	2.44	12.09	0.33
Receivables	2.55	3.69	6.5	2.44	12.09	0.33
Prepaid Expenses	11.02	11.2	12.24	12.7	14.09	2.89
Total Current Assets	528.99	509.54	550.65	628.3	874.71	339.54
Property, Plant & Equipment	10.3	9.98	10.73	6.77	7.4	1.35
Long-Term Investments	74.61	160.35	100.54	118.23	-	-
Other Long-Term Assets	9.17	7.1	5.67	1.7	2.6	3.66
Total Assets	623.08	686.98	667.59	754.99	884.71	344.56
Accounts Payable	6.25	8.5	11.29	7.66	5.15	3.03
Accrued Expenses	61.03	29.12	15.62	19.73	17.16	7.49
Current Portion of Leases	1.52	1.34	1.25	0.84	0.77	-
Current Unearned Revenue	1.48	1.4	2.06	13.78	281.05	4.49
Other Current Liabilities	-	-	9.79	-	-	-
Total Current Liabilities	70.27	40.36	40.01	42	304.12	15
Long-Term Leases	3.61	3.76	4.81	3.84	4.57	-
Other Long-Term Liabilities	55.4	52.56	47.54	45.82	23.2	6.36
Total Liabilities	129.28	96.68	92.36	91.66	331.89	21.36
Common Stock	0.04	0.04	0.04	0.04	0.04	0.04
Additional Paid-In Capital	633.07	616.04	463.8	435.67	413.18	396.44
Retained Earnings	-123.12	-9.78	124.63	237.28	140.62	-73.9
Comprehensive Income & Other	-16.19	-16	-13.24	-9.64	-1.02	0.62
Total Common Equity	493.8	590.29	575.23	663.33	552.82	323.2
Shareholders' Equity	493.8	590.29	575.23	663.33	552.82	323.2
Total Liabilities & Equity	623.08	686.98	667.59	754.99	884.71	344.56
Total Debt	5.13	5.1	6.06	4.67	5.34	-
Net Cash (Debt)	510.3	489.55	525.86	608.49	843.2	336.33
Net Cash Growth	-9.80%	-6.90%	-13.58%	-27.83%	150.71%	1592.80%
Net Cash Per Share	11.79	12.10	14.70	16.11	22.32	22.30
Filing Date Shares Outstanding	44.21	38.19	35.84	35.72	35.51	35.1
Total Common Shares Outstanding	38.27	36.57	35.84	35.61	35.47	35.04
Working Capital	458.72	469.18	510.64	586.3	570.59	324.55
Book Value Per Share	12.90	16.14	16.05	18.63	15.59	9.22
Tangible Book Value	493.8	590.29	575.23	663.33	552.82	323.2
Tangible Book Value Per Share	12.90	16.14	16.05	18.63	15.59	9.22
Machinery	6.6	5.76	4.9	4.34	3.97	3.16
Leasehold Improvements	4.62	4.05	4.18	1.24	1.07	0.86

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q